Company intelligence / Profile preview

Medical & Commercial International

London, England, United Kingdom

Ownership: Private
Employees: ~17
Development stage: Other

Overview

MCI insures and finances clinical trials using advanced AI platforms for risk assessment, aiming to de-risk early-stage drug development for biotech, pharma, and medical device companies

Modalities: Small moleculeBiologicMedical devicemAbsVaccineGene therapyCell therapyAntibody
Industry: Investors

Partnerships

Lloyd's of London syndicateGATC HealthAcrisure Re Corporate Advisory and Solutions (ARCAS)

Beyond the preview

Go deeper on Medical & Commercial International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medical & Commercial International.

Explore the full profile